Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial (2018)
- Authors:
- USP affiliated authors: YASUNAKA, JENICER KAZUMI UMADA YOKOYAMA - ICB ; ULIANA, SILVIA RENI BORTOLIN - ICB
- Unidade: ICB
- DOI: 10.1111/tmi.13119
- Subjects: PARASITOLOGIA; LEISHMANIOSE CUTÂNEA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2018
- Source:
- Título: Tropical Medicine & International Health
- ISSN: 1365-3156
- Volume/Número/Paginação/Ano: v. 23, n. 9, p. 936-942, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MACHADO, Paulo R. L. et al. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial. Tropical Medicine & International Health, v. 23, n. 9, p. 936-942, 2018Tradução . . Disponível em: https://doi.org/10.1111/tmi.13119. Acesso em: 12 jan. 2026. -
APA
Machado, P. R. L., Ribeiro, C. S., França‐Costa, J., Dourado, M. E. F., Trinconi, C. T., Yokoyama‐Yasunaka, J. K. U., et al. (2018). Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial. Tropical Medicine & International Health, 23( 9), 936-942. doi:10.1111/tmi.13119 -
NLM
Machado PRL, Ribeiro CS, França‐Costa J, Dourado MEF, Trinconi CT, Yokoyama‐Yasunaka JKU, Malta‐Santos H, Borges VM, Carvalho EM, Uliana SRB. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial [Internet]. Tropical Medicine & International Health. 2018 ; 23( 9): 936-942.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1111/tmi.13119 -
Vancouver
Machado PRL, Ribeiro CS, França‐Costa J, Dourado MEF, Trinconi CT, Yokoyama‐Yasunaka JKU, Malta‐Santos H, Borges VM, Carvalho EM, Uliana SRB. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial [Internet]. Tropical Medicine & International Health. 2018 ; 23( 9): 936-942.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1111/tmi.13119 - Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
- Synthesis and in vitro activity of limonene derivatives against Leishmania and Trypanosoma
- In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
- The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
- The extraordinary case of a woman with a 30-year-long diffuse Leishmaniasis cured with one single ampoule of intranasal pentavalent antimoniate
- Combination therapy with Tamoxifen and Amphotericin B in experimental cutaneous Leishmaniasis
- Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool
- Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library
- Topical tamoxifen in the therapy of cutaneous leishmaniasis
- Antileishmanial activity of the estrogen receptor modulator raloxifene
Informações sobre o DOI: 10.1111/tmi.13119 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
